223 related articles for article (PubMed ID: 28506553)
1. Inhibition of 12/15-LO ameliorates CVB3-induced myocarditis by activating Nrf2.
Ai F; Zheng J; Zhang Y; Fan T
Chem Biol Interact; 2017 Jun; 272():65-71. PubMed ID: 28506553
[TBL] [Abstract][Full Text] [Related]
2. Melittin ameliorates CVB3-induced myocarditis via activation of the HDAC2-mediated GSK-3β/Nrf2/ARE signaling pathway.
Wang T; Zhang J; Xiao A; Liu W; Shang Y; An J
Biochem Biophys Res Commun; 2016 Nov; 480(1):126-131. PubMed ID: 27693786
[TBL] [Abstract][Full Text] [Related]
3. Heme oxygenase-1 mediates oxidative stress and apoptosis in coxsackievirus B3-induced myocarditis.
Ursu ON; Sauter M; Ettischer N; Kandolf R; Klingel K
Cell Physiol Biochem; 2014; 33(1):52-66. PubMed ID: 24401606
[TBL] [Abstract][Full Text] [Related]
4. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B aggravates coxsackievirus B3-induced myocarditis through activating the inflammasome and promoting pyroptosis.
Wang Y; Jia L; Shen J; Wang Y; Fu Z; Su SA; Cai Z; Wang JA; Xiang M
PLoS Pathog; 2018 Jan; 14(1):e1006872. PubMed ID: 29360865
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin7A aggravates coxsackievirusB3-induced viral myocarditis by increasing α1β1-integrin macrophages and subsequent enhanced inflammatory response.
Wu X; Meng Y; Wang C; Yue Y; Dong C; Xiong S
J Mol Cell Cardiol; 2018 Jan; 114():48-57. PubMed ID: 29108785
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocyte-specific deletion of Senp2 contributes to CVB3 viral replication and inflammation.
Wang K; Jiang Z; Lu X; Zhang Y; Yuan X; Luo D; Lin Z; Zuo Y; Luo Q
Int Immunopharmacol; 2020 Nov; 88():106941. PubMed ID: 33182061
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells.
Zhu H; Lou C; Liu P
Virol J; 2015 Nov; 12():189. PubMed ID: 26578236
[TBL] [Abstract][Full Text] [Related]
11. MiR-1/133 attenuates cardiomyocyte apoptosis and electrical remodeling in mice with viral myocarditis.
Li W; Liu M; Zhao C; Chen C; Kong Q; Cai Z; Li D
Cardiol J; 2020; 27(3):285-294. PubMed ID: 30994182
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-30a-5p silencing polarizes macrophages toward M2 phenotype to alleviate cardiac injury following viral myocarditis by targeting SOCS1.
Zhang Y; Cai S; Ding X; Lu C; Wu R; Wu H; Shang Y; Pang M
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1348-H1360. PubMed ID: 33416455
[TBL] [Abstract][Full Text] [Related]
13. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Drp1 attenuates mitochondrial damage and myocardial injury in Coxsackievirus B3 induced myocarditis.
Lin L; Zhang M; Yan R; Shan H; Diao J; Wei J
Biochem Biophys Res Commun; 2017 Mar; 484(3):550-556. PubMed ID: 28131843
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
[TBL] [Abstract][Full Text] [Related]
16. Remission of CVB3-induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up-regulation.
Gui J; Chen R; Xu W; Xiong S
J Cell Mol Med; 2015 Apr; 19(4):850-64. PubMed ID: 25728713
[TBL] [Abstract][Full Text] [Related]
17. The protection effects of survivin in the cell model of CVB3-induced viral myocarditis.
Wu R; Wu T; Li P; Wang Q; Shi Y; Zhan Y; Zhang S; Xia T; Wang Z; Lv H
Heart Vessels; 2020 Aug; 35(8):1171-1179. PubMed ID: 32328712
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
19. Ulinastatin Protects against CVB3-Induced Acute Viral Myocarditis through Nrf2 Activation.
Song F; Kong F; Zhang H; Zhou Y; Li M
Inflammation; 2018 Jun; 41(3):803-810. PubMed ID: 29383542
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA Ameliorate Coxsackie Virus B3-Induced Viral Myocarditis through the Inhibition of Inflammation and Modulation T Helper 1/T Helper 2 Balance in Mice.
Guo G; Zhao Q; Wang Q; Li E
Pharmacology; 2019; 103(3-4):136-142. PubMed ID: 30602153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
